Hinge Health, Inc. <HNGE.N>: Truist Securities raises target price to $112 from $85
HNGE•Related News
Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases
STTK•
Neurogene Q2 adjusted loss per share misses estimates on employee costs
NGNE•
EVgo opens new flagship fast-charging site near GM technical center in Detroit metro area
EVGO•
Hemab Therapeutics Reports Second Quarter 2026 Financial Results And Provides Corporate Update
COAG•
Zura Bio Q2 FY26 net loss widens to $26.3 million; R&D expense more than doubled to $20.7 million
ZURA•